SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE l3D
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Isomedix Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
4648901027
- --------------------------------------------------------------------------------
(CUSIP Number)
with a copy to:
Krista L. Ward George J. Mazin
Stark Investments Lowenstein, Sandler, Kohl,
1500 West Market Street Fisher & Boylan, P.A.
Mequon, WI 53092 65 Livingston Avenue
(414) 241-1810 Roseland, New Jersey 07068
(201) 992-8700
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number
of Person Authorized to Receive
Notices and Communications)
August 15, 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule l3G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule l3d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
CUSIP NO. 4648901027
- --------------------------------------------------------------------------------
1) Names of Reporting Persons (S.S. or I.R.S. Identification Nos. of Above
Persons):
Michael A. Roth and Brian J. Stark (filing as joint filers pursuant to Rule
13(d)1(f)(1))
- --------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) Not
(b) Applicable
- --------------------------------------------------------------------------------
3) SEC Use Only
- --------------------------------------------------------------------------------
4) Source of Funds (See Instructions):WC
- --------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d)
or 2(e): Not Applicable
- --------------------------------------------------------------------------------
6) Citizenship or Place of Organization:
Wisconsin
- --------------------------------------------------------------------------------
Number of 7) Sole Voting Power: 0
---------------------------------------
Shares Beneficially 8) Shared Voting Power: 365,000*
--------------------------------------
Owned by
Each Reporting 9) Sole Dispositive Power: 0
---------------------------------------
Person With: 10) Shared Dispositive Power: 365,000*
---------------------------------------
- --------------------------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person:
365,000*
- --------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions):
Not Applicable
- --------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11):
5.65%*
- --------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions): IN
- --------------------------------------------------------------------------------
* Includes 182,500 shares of the Issuer's common stock beneficially owned
by Reliant Trading and 182,500 shares of the Issuer's common stock
beneficially owned by Shepherd Trading Limited. See Item 2 and Item 5
for additional details.
Item 1: Security and Issuer:
This statement relates to the Common Stock, par value $.01 per share, of
Isomedix Inc. ("Shares"). The issuer has principal executive offices located at
11 Apollo Drive, Whippany, New Jersey 07981.
Item 2: Identity and Background
1.
a) Name: Brian J. Stark
b) Residence or Business Address: 1500 West Market Street
Mequon, WI 53092
c) Occupation: Investment Fund Manager
Staro Asset Management, L.L.C., Stark & Roth,
Inc., Staro Partners
1500 West Market Street
Mequon, WI 53092
d) Convictions: none
e) Civil Proceedings: none
f) Citizenship: United States
2.
a) Name: Michael A. Roth
b) Residence or Business Address: 1500 West Market Street
Mequon, WI 53092
c) Occupation: Investment Fund Manager
Staro Asset Management, L.L.C.,
Stark & Roth, Inc., Staro Partners
1500 West Market Street
Mequon, WI 53092
d) Convictions: none
e) Civil Proceedings: none
f) Citizenship: United States
3.
a) Name: Staro Partners
b) State of Organization: Wisconsin
c) Principal Business: Securities Trading
d) Address of principal business: 1500 West Market Street
Mequon, WI 53092
e) Address of Principal Office: same
f) Convictions: none
g) Civil proceedings: none
4.
a) Name: Reliant Trading
b) State of Organization: Wisconsin
c) Principal Business: Securities Trading
d) Address of principal business: 1500 West Market Street
Mequon, WI 53092
e) Address of Principal Office: same
f) Convictions: none
g) Civil proceedings: none
5.
a) Name: Shepherd Trading Limited
b) State of Organization: British Virgin Islands
c) Principal Business: Securities Trading
Address of principal business: c/o International Fund
Administration, Ltd.
48 Par-La Ville Road, Suite 464
Hamilton, HM 11 Bermuda
d) Address of Principal Office: same
e) Convictions: none
f) Civil proceedings: none
Item 3: Source and Amount of Funds or Other Consideration
All funds used by Reliant Trading to purchase Shares acquired by
Reliant Trading were obtained from the capital contributed by the limited
partners of Stark Investments, L.P. and general margin financing from brokers.
The amount of funds used in making the purchases was $3,700,330. The funds used
by Shepherd Trading Limited to purchase the Shares acquired by Shepherd Trading
Limited were obtained from the capital contributed by the shareholders of
Shepherd Fund Limited. The amount of funds used in making the purchases was
$3,700,330.
Item 4: Purpose of Transaction
The acquisition of the Shares by Reliant Trading and by Shepherd
Trading Limited are solely for investment purposes. Further acquisitions, sales
or short sales of securities of the Issuer may be made for investment purposes,
however, neither reporting person has present plans or intentions which relate
to or would result in any of the transactions required to be described in Item 4
of Schedule 13D.
Item 5: Interest in Securities of the Issuer
Based upon the information contained in Isomedix Inc.'s 10 Q for the
fiscal quarter ending June 30, 1997, there were issued and outstanding 6,459,098
Shares. Messrs. Stark and Roth beneficially own 365,000 Shares or 5.65% of the
Shares. 182,500 of such Shares are held by Reliant Trading. Messrs. Stark and
Roth have shares power to vote or direct the vote and shared power to dispose or
direct the disposition of the 182,500 Shares by virtue of their position as
members of Staro Asset Management, L.L.C., the managing partner of Reliant
Trading. 182,500 Shares are held by Shepherd Trading Limited. Messrs. Stark and
Roth have shares power to vote or direct the vote and shared power to dispose or
direct the disposition of the 182,500 Shares by virtue of their position as
investment manager of Shepherd Trading Limited.
The following Table details the transactions by Reliant Trading and
Shepherd Trading Limited in the Common Stock of Isomedix Inc. during the past 60
days:
Shepherd Trading Limited
Date Quantity Price Transaction Type
8/15/97 150,000 $20.25 Open Mkt. Purchase
8/14/97 12,500 20.25 Open Mkt. Purchase
8/13/97 20,000 20.226 Open Mkt. Purchase
Reliant Trading
Date Quantity Price Transaction Type
8/15/97 150,000 $20.25 Open Mkt. Purchase
8/14/97 12,500 20.25 Open Mkt. Purchase
8/13/97 20,000 20.226 Open Mkt. Purchase
No other entity controlled by the reporting persons has traded Isomedix
Inc. Common Stock within the past 60 days.
<PAGE>
Item 6: Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
See Item 2.
Item 7: Material to be filed as exhibits.
Exhibit 1: Agreement as to joint filing.
<PAGE>
EXHIBIT 1
AGREEMENT AS TO JOINT FILING
Dated August 26, 1997
The undersigned hereby agree that the Schedule 13D with
respect to Isomedix Inc. dated as of the date hereof is filed on behalf of each
of the undersigned jointly pursuant to Rule 13d-1(f)(1).
/s/Brian J. Stark
--------------------
Brian J. Stark
/s/Michael A. Roth
--------------------
Michael A. Roth
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of the undersigned's
knowledge and belief, the undersigned hereby certifies that the information set
forth in this statement is true, complete and correct.
August 26, 1997
/s/Brian J. Stark
---------------------
Brian J. Stark
/s/ Michael A. Roth
---------------------
Michael A. Roth
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).
